Navigation Links
1 in 5 Pharmacies Hinders Teens' Access to 'Morning-After' Pill: Study
Date:3/26/2012

By Jenifer Goodwin
HealthDay Reporter

MONDAY, March 26 (HealthDay News) -- Nearly one in five U.S. pharmacies gave out misinformation to researchers posing as 17-year-old girls seeking emergency contraception, often saying that it was "impossible" for girls to get the pill, a new study finds.

About 3 percent of researchers posing as physicians also received wrong information about the availability of emergency contraception, also known as the "morning-after" pill.

The findings show that 17-year-olds in need of emergency contraception to prevent unintended pregnancy face significant barriers in accessing it, the study authors said. According to U.S. federal regulations, girls 17 and older can buy emergency contraception without a prescription if they show proof of age, while girls 16 and younger need a doctor's prescription.

"What we found was that emergency contraception was pretty available, in that 80 percent had it on the shelf that day," said lead study author Dr. Tracey Wilkinson, a general pediatrics fellow at Boston University School of Medicine and Boston Medical Center. "However, when teenagers asked if they could get the medicine, they were [sometimes] told they couldn't get it at all, not with a prescription, not over-the-counter, just simply based on their age."

The study, published online March 26, appears in the April print issue of Pediatrics.

In the study, researchers called all the commercial pharmacies in five major U.S. cities: Austin, Texas; Cleveland; Nashville, Tenn.; Philadelphia; and Portland, Ore. Each of the 943 pharmacies got called twice, once by a "17-year-old girl" and once by a "physician." Researchers spoke to pharmacists, pharmacy technicians or unidentified pharmacy staff.

Four in five callers were told the pharmacy had emergency contraception in stock. However, 19 percent of 17-year-old callers were told that they could not obtain emergency contracepti
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Linking Pharmacies With Doctors Offices Can Improve Med Adherence: Study
2. Illegal Online Pharmacies Prey on Consumers
3. Study shows pharmacies software systems miss potentially dangerous interactions
4. PharmacyChecker.com Reports Decrease in Brand Name Drug Prices From Canadian and Other International Online Pharmacies
5. Two Tulsa Pharmacies Penalized for Missing Prescription Drugs
6. Aurora-A hinders tumor-suppressor to allow chemotherapy resistance
7. More Evidence That Alcohol Hinders Good Sleep
8. Patient personality hinders detection of depression
9. Drinking Scenes in Movies May Spur Teens to Do the Same
10. Web-Based Therapy May Help Teens With Chronic Fatigue
11. Strict Underage Drinking Laws May Deter Delinquency in Teens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... (PRWEB) December 25, 2014 Parker & ... outstanding customer service and affordable quality regarding heating, cooling ... announces recognition in 2014 by the “Queen of Clean” ... has earned an impressive reputation over the years for ... a wide range of contractor services for both homeowners ...
(Date:12/24/2014)... Epigenetics finds applications in a large number of fields ... biology, and research for metabolic and genetic disorders. It ... used techniques for the discovery and development of cancer ... rapidly growing worldwide. In 2012, there were 14.1 million ... million people living with cancer (within five years of ...
(Date:12/24/2014)... December 24, 2014 Risperdal lawsuit ( ... mass tort litigation currently underway in Pennsylvania’s Philadelphia Court ... of December 24, 2014, court documents indicate that 1,183 ... of individuals who developed gynecomastia (male breast growth) and ... the Court indicates that this represents an increase of ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 The ... that allege the blood thinner caused life-threatening episodes ... a leadership structure for the proceeding, Bernstein Liebhard ... 17th, the Court plans to select lawyers to ... also plans on appointing a Plaintiffs’ Steering Committee, ...
(Date:12/24/2014)... TX (PRWEB) December 25, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. Stivarga is a drug which is used ... drug is orally administered and is also prescribed to ... drug which is FDA approved is a multi-kinase inhibitor ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... is Leading Proponent for Single-Payer Healthcare ... Reforms - ,Medicare ... camera on the,fastest-growing union in America -- and the nation,s ... California Nurses,Association/National Nurses Organizing Committee,s fight for guaranteed,single-payer healthcare in ...
... odds of heart attack, death, study finds , , THURSDAY, May ... can hear when passing a stethoscope over a main artery ... attack and death from heart disease and stroke, a new ... (pronounced brew-ee) -- is caused by turbulent blood flow due ...
... 6, 2008) The American Society of Hematology (ASH) ... for its 2008 Minority Medical Student Award Program (MMSAP), ... in hematology research. Under the program, each award recipient ... a career development mentor, travel stipends to attend medical ...
... $0.18 In Line with Previously Announced ... Expectations, ... largest air medical transportation company in the,world, reported financial results for the ... flight volumes. For the quarter,revenue increased 45.0% to $118.1 million from $81.5 ...
... Corporation is launching a,third dental industry-focused online Tradeshow, ... is now open and available at, http://www.ddstechfair.com . ... bring dental professionals together with,colleagues and manufacturers at ... Tech Fair is designed to give the dental ...
... role in development of defective cells in type 2 diabetics ... an important gene during fetal development appears to increase vulnerability ... , Intrauterine growth retardation (IUGR), which causes low birth ... type 2 diabetes and other diseases when a child grows ...
Cached Medicine News:Health News:Bill Moyers' Journal to Feature California Nurses Association/National Nurses Organizing Committee in Friday, May 9th Episode 2Health News:Noise in Artery Could Warn of Heart Risk 2Health News:Minority medical students receive support to increase diversity in hematology 2Health News:Air Methods Reports 1Q2008 Results and 2Q2008 Update 2Health News:Air Methods Reports 1Q2008 Results and 2Q2008 Update 3Health News:Air Methods Reports 1Q2008 Results and 2Q2008 Update 4Health News:Air Methods Reports 1Q2008 Results and 2Q2008 Update 5Health News:Air Methods Reports 1Q2008 Results and 2Q2008 Update 6Health News:PennWell Announces DDS Tech Fair 2Health News:Fetal Gene May Contribute to Diabetes Risk 2
(Date:12/24/2014)... , December 24, 2014 ... on Global Disposable Syringe Industry of 178 ... online business intelligence library. The ... Syringe Industry is a professional and deep ...  For overview analysis, the report introduces Disposable ...
(Date:12/24/2014)... 2014 Tianyin Pharmaceutical Co., Inc. (NYSE ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... that the Company achieved the Public Notice (Gong ... certificate of TPI,s Qionglai Facility (QLF) from the ... notice period is a significant procedure of GMP ...
(Date:12/22/2014)... Mass. , Dec. 22, 2014 ... leading manufacturer of innovative dialysis products, announced today ... has cleared its System One™ to perform hemodialysis ... known as home nocturnal hemodialysis. NxStage,s® System One ... by the FDA for this indication. ...
Breaking Medicine Technology:World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3
... - First of three ongoing randomized chemotherapy combination trials ... HGS-ETR1 in the treatment of specific cancers -, ... HGSI ) today reported initial topline results from,an ... receptor antibody,HGS-ETR1 (mapatumumab) in combination with bortezomib (Velcade) in ...
... This Common and Successful Surgery, ROCHESTER, Minn., ... issue of Mayo Clinic Health Letter. You may,cite ... is allowed for a,fee. Mayo Clinic Health Letter ... your editorial policies permit: Visit, http://www.HealthLetter.MayoClinic.com or ...
Cached Medicine Technology:Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 2Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 3Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 4Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 5Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 6September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging 2September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging 3September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: